Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)
China · Delayed Price · Currency is CNY 14.41
-0.36 (-2.44%)
Sep 2, 2026, 2:19 PM CST
Beijing Scitop Bio-tech Revenue
Beijing Scitop Bio-tech had revenue of 84.51M CNY in the quarter ending June 30, 2026, a decrease of -1.43%. This brings the company's revenue in the last twelve months to 372.08M, up 13.41% year-over-year. In the year 2025, Beijing Scitop Bio-tech had annual revenue of 365.92M with 20.85% growth.
Revenue (ttm)
372.08M
Revenue Growth
+13.41%
P/S Ratio
10.46
Revenue / Employee
900.93K
Employees
413
Market Cap
3.89B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 365.92M | 63.13M | 20.85% |
| Dec 31, 2024 | 302.79M | 3.55M | 1.19% |
| Dec 31, 2023 | 299.24M | -69.92M | -18.94% |
| Jan 1, 2023 | 369.17M | 4.55M | 1.25% |
| Dec 31, 2021 | 364.62M | 25.46M | 7.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Anhui Huaheng Biotechnology | 3.00B |
| Hefei Lifeon Pharmaceutical | 1.51B |
| Xiangxue Pharmaceutical | 1.48B |
| Kexing Biopharm | 1.44B |
| Pulike Biological Engineering | 1.02B |
| Beijing Bohui Innovation Biotechnology Group | 816.14M |
| Lifecome Biochemistry | 470.43M |
| Assure Tech (Hangzhou) | 407.16M |
Beijing Scitop Bio-tech News
- 9 days ago - Beijing Scitop Bio-tech Quarterly report: Q2 2026 - Filings
- 4 months ago - Beijing Scitop Bio-tech Annual report: Q4 2025 - Filings
- 4 months ago - Beijing Scitop Bio-tech Quarterly report: Q1 2026 - Filings
- 11 months ago - Beijing Scitop Bio-tech Quarterly report: Q3 2025 - Filings